- ACTIVE STOCK TRADERS: Get full access to Jim Cramer's thoughts for less than $3/week - sometimes before he says them on TV! Start with a 14-Day Free Trial.
Despite tepid market reaction, and analyst skepticism, there might be some upside for TMO.
Thermo Fisher Scientific (TMO) has reportedly offered $30 billion to acquire Illumina (ILMN).
Illumina is in breakout mode and could be headed much higher.